-
Mashup Score: 1
The expanded Indication now includes children of all ages with achondroplasia, the most common form of skeletal dysplasia leading to disproportionate short stature.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0FDA Approves Vosoritide for Achondroplasia in Children Under 5 Years - 5 month(s) ago
The expanded Indication now includes children of all ages with achondroplasia, the most common form of skeletal dysplasia leading to disproportionate short stature.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Public meeting: FDA Rare Disease Day 2023 - 1 year(s) ago
FDA will host Rare Disease Day, a virtual public meeting, on February 27, 2023, 9:00 am – 4:45 pm ET, in global observance of Rare Disease Week.
Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Public meeting: FDA Rare Disease Day 2023 - 1 year(s) ago
FDA will host Rare Disease Day, a virtual public meeting, on February 27, 2023, 9:00 am – 4:45 pm ET, in global observance of Rare Disease Week.
Categories: General Medicine News, Latest HeadlinesTweet
BREAKING: The #FDA has approved the supplemental New Drug Application for vosoritide for children under 5 years with achondroplasia with open epiphyses. Read more: https://t.co/jLynD1IVvu #RareDisease